The three retrospective analyses found associations between GLP-1 agonists and multiple outcomes including incident and recurrent alcohol use disorder, alcohol intoxication among individuals with alcohol use disorder, and hospitalizations related to alcohol use, substance use, and somatic health conditions. The gene discussed is GCG; the disease is alcohol abuse.